INS and COVID-19: Our previous unblinded retrospective study of the DG6 in critically ill COVID-19 patients showed improved glycemic control with CGM-directed insulin therapy and MARD of 14.8%.18 Sensors were placed on the posterior upper arm, and CGM values were time-matched to reference values within five minutes.